Screener
AngioDynamics ANGO Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: AngioDynamics’s 10-Q, filed April 2, 2026.
- Filed
- Apr 2, 2026, 12:00 AM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-023008
| Line item | Three Months Ended / Feb 28, 2026 | Three Months Ended / Feb 28, 2025 | Nine Months Ended / Feb 28, 2026 | Nine Months Ended / Feb 28, 2025 |
|---|---|---|---|---|
| Other expense: | ||||
| Interest income (expense), net | (88) | 135 | (194) | 975 |
| Other income, net | 4,967 | 5,430 | 4,661 | 5,269 |
| Total other income, net | 4,879 | 5,565 | 4,467 | 6,244 |
| Loss before income tax benefit | (8,072) | (4,409) | (25,265) | (27,922) |
| Income tax (benefit) expense | 12 | (2) | 72 | 21 |
| Net loss | $(8,084) | $(4,407) | $(25,337) | $(27,943) |
| Loss per share |
Item 1. Financial Statements.
FAQ
- What is AngioDynamics's other income (expense)?
- AngioDynamics (ANGO) reported other income (expense) of $4.88M in Q4 2025.
- How has AngioDynamics's other income (expense) changed year-over-year?
- AngioDynamics's other income (expense) decreased by 12.3% year-over-year, from $5.57M to $4.88M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about AngioDynamics's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude